Genetic Causes of Infantile Spasms in Young Children
This study looked at the genetic causes of infantile spasms in children under two years old in Peru.
-
-
New Genes Identified as Potential Epilepsy Treatment Targets
This study looked at how genes might influence epilepsy in mice.
-
Prior Authorization Creates Barriers for Neurology Patients
This study looked at how prior authorization (PA) policies affect access to medications for people with six common neurological conditions, including epilepsy.
-
Devices & Neuromodulation | Drug-Resistant Epilepsy | Epilepsy Research Summaries | Imaging & EEG | New Studies | Safety & First Aid
New Device Safely Records Brain Activity for Epilepsy Care
Researchers studied a new device called the EP-01, which is designed to record brain activity from inside blood vessels in patients with drug-resistant epilepsy.
-
CLN2 Disease: Study Reveals Diagnostic Delays and Challenges
This study looked at a rare genetic disorder called neuronal ceroid lipofuscinosis type 2 (CLN2 disease) in children in France.
-
New Seizure Classification Works Well in Referral Centers
A recent study looked at how well the updated International League Against Epilepsy (ILAE) seizure classification works in secondary referral centers, which are specialized clinics for epilepsy care.
-
Cenobamate Works Well for Adults with Epilepsy and ID
This study looked at how well cenobamate, a medication for epilepsy, works in adults with intellectual disability (ID) compared to those without ID.
-
Prenatal Antiseizure Medications May Impact Child Development
This study looked at how being exposed to antiseizure medications (ASMs) before birth affects children’s cognitive development from ages 2 to 6.
-
Devices & Neuromodulation | Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | New Studies | Safety & First Aid
Non-Invasive Treatments Show Promise for Drug-Resistant Epilepsy
Researchers studied different non-invasive neurostimulation treatments for people with drug-resistant epilepsy, which is a type of epilepsy that does not respond well to medications.
